ERC Grantees 2019

In 2019, the European Research Council has granted 7 Consolidator Grants, 2 Starting Grants and 3 Synergy Grants to Inserm researchers. Learn who they are and the name of their research program.

Consolidator Grants

Pascale Bomont - Inserm Unit 1051 (Montpellier). Neurofilaments in Health and neurodegenerative diseases - NeuroFish

Ruben Hartkoorn - Inserm Unit 1019 (Lille). BioInspired Clicked Siderophore-Antibiotics - ANTIBIOCLICKS

Gilles Huberfeld – Inserm Unit 1050 (Paris). Oncometabolitic control of tumor growth and epileptogenesis in IDH mutated gliomas: D2HG signaling mechanism - GliomaSignals

Annarita Miccio – Inserm Unit 1163 (Paris). Development of Innovative Therapeutic Strategies for betahemoglobinopathies - DITSB

Pamela Schnupf – Inserm Unit 1151 (Paris). Deciphering the niche adaptations of a gut commensal involved in educating the host immune system - NICHEADAPT

Matias Simons – Inserm Unit 1151 (Paris). Deciphering the niche adaptations of a gut commensal involved in educating the host immune system - NICHEADAPT

Mathilde Touvier – Inserm Unit 1153 (Bobigny). Exposure to ‘cocktails’ of food additives and chronic disease risk - ADDITIVES). More about Mathilde Touvier, 2019 Research Prize

Starting Grant

Camille Berthelot – Inserm Unit 1024 (Paris). The evolution of menstruation in primates – EVOMENS

Meadhbh Brennan – Inserm Unit 1238 (Nantes). Extracellular vesicles for bone regeneration – alternatives to stem-cell therapy - EVEREST

Synergy Grant

Nathalie Bajos (Inserm unit 1018, Villejuif) et Michelle Kelly (Inserm unit 1027, Toulouse). Gender and Health Inequalities :  from embodiment to health care cascade - GENDHI

Fabrice Wendling - Inserm unit 1099 (Rennes). Controlling epileptic brain networks with computationally optimized weak electric fields - GALVANI

Olivier Delattre - Inserm unit 830 (Institut Curie, Paris). Using cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental path - KILL-OR-DIFFERENTIAT